Src Inhibition with Saracatinib Reverses Fulvestrant Resistance in ER-Positive Ovarian Cancer Models In Vitro and In VivoArticle
Simpkins, Fiona, Hevia-Paez, Pedro, Sun, Jun et al. (2012). Src Inhibition with Saracatinib Reverses Fulvestrant Resistance in ER-Positive Ovarian Cancer Models In Vitro and In Vivo
. CLINICAL CANCER RESEARCH, 18(21), 5911-5923. 10.1158/1078-0432.CCR-12-1257
Simpkins, Fiona, Hevia-Paez, Pedro, Sun, Jun et al. (2012). Src Inhibition with Saracatinib Reverses Fulvestrant Resistance in ER-Positive Ovarian Cancer Models In Vitro and In Vivo
. CLINICAL CANCER RESEARCH, 18(21), 5911-5923. 10.1158/1078-0432.CCR-12-1257